Clinical Trial Update: A Phase I Study of GZR18 Injection in Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase I trial of GZR18 Injection in healthy subjects has completed, sponsored by Gan and Lee Pharmaceuticals (USA), investigating Type 2 diabetes mellitus and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• GZR18 Injection

Snippet

Sponsor: Gan and Lee Pharmaceuticals, USA | Conditions: Type 2 Diabetes, Overweight and Obesity | Phase 1 | Status: COMPLETED